PT88261A - Processo para a preparacao de nucleosidos com efeito terapeutico - Google Patents

Processo para a preparacao de nucleosidos com efeito terapeutico

Info

Publication number
PT88261A
PT88261A PT88261A PT8826188A PT88261A PT 88261 A PT88261 A PT 88261A PT 88261 A PT88261 A PT 88261A PT 8826188 A PT8826188 A PT 8826188A PT 88261 A PT88261 A PT 88261A
Authority
PT
Portugal
Prior art keywords
preparation
therapeutic effect
therapeutic
effect
Prior art date
Application number
PT88261A
Other languages
English (en)
Other versions
PT88261B (pt
Inventor
Thomas Anthony Krenitsky
Lilia Marie Beauchamp
Original Assignee
Wellcome Found
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26292613&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PT88261(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from GB878719367A external-priority patent/GB8719367D0/en
Priority claimed from GB878725939A external-priority patent/GB8725939D0/en
Application filed by Wellcome Found filed Critical Wellcome Found
Publication of PT88261A publication Critical patent/PT88261A/pt
Publication of PT88261B publication Critical patent/PT88261B/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D473/00—Heterocyclic compounds containing purine ring systems
    • C07D473/02—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6
    • C07D473/18—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 one oxygen and one nitrogen atom, e.g. guanine
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D473/00—Heterocyclic compounds containing purine ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A61P31/22—Antivirals for DNA viruses for herpes viruses

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Communicable Diseases (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Medicinal Preparation (AREA)
PT88261A 1987-08-15 1988-08-12 Processo para a preparacao de nucleosidos com efeito terapeutico PT88261B (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB878719367A GB8719367D0 (en) 1987-08-15 1987-08-15 Therapeutic compounds
GB878725939A GB8725939D0 (en) 1987-11-05 1987-11-05 Therapeutic compounds

Publications (2)

Publication Number Publication Date
PT88261A true PT88261A (pt) 1989-06-30
PT88261B PT88261B (pt) 1995-03-01

Family

ID=26292613

Family Applications (1)

Application Number Title Priority Date Filing Date
PT88261A PT88261B (pt) 1987-08-15 1988-08-12 Processo para a preparacao de nucleosidos com efeito terapeutico

Country Status (30)

Country Link
EP (2) EP0596542B1 (pt)
JP (2) JPH0662623B2 (pt)
KR (2) KR960002849B1 (pt)
CN (1) CN1033701C (pt)
AP (2) AP160A (pt)
AT (1) ATE138660T1 (pt)
AU (1) AU612393C (pt)
CS (1) CS276903B6 (pt)
CY (1) CY1833A (pt)
DE (1) DE3855333T2 (pt)
DK (2) DK170045B1 (pt)
ES (1) ES2087639T3 (pt)
FI (1) FI89713C (pt)
GR (1) GR3020372T3 (pt)
HU (1) HU201071B (pt)
IE (1) IE65551B1 (pt)
IL (1) IL87434A (pt)
LU (1) LU88746I2 (pt)
LV (1) LV5264A3 (pt)
MC (1) MC1968A1 (pt)
MX (1) MX9203418A (pt)
MY (1) MY103760A (pt)
NL (1) NL960001I2 (pt)
NO (2) NO167805C (pt)
NZ (1) NZ225809A (pt)
PL (1) PL158285B1 (pt)
PT (1) PT88261B (pt)
SA (1) SA95160244B1 (pt)
SG (1) SG26346G (pt)
SU (1) SU1634138A3 (pt)

Families Citing this family (44)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AP160A (en) * 1987-08-15 1991-11-18 The Wellcome Foundation Ltd Therapeutic acyclic nucleosides.
GB8816760D0 (en) * 1988-07-14 1988-08-17 Wellcome Found Therapeutic compounds
GB8829571D0 (en) * 1988-12-19 1989-02-08 Wellcome Found Antiviral compounds
ATE123285T1 (de) * 1988-12-19 1995-06-15 Wellcome Found Antivirale pyrimidin- und purinverbindungen, verfahren zu ihrer herstellung und sie enthaltende pharmazeutische präparate.
DE4008858A1 (de) * 1990-03-20 1991-09-26 Hoechst Ag Substituierte purine, verfahren zu ihrer hertellung sowie ihre verwendung als antivirale mittel
ATE199719T1 (de) * 1993-06-10 2001-03-15 Rolabo Sl Verfahren zur herstellung von aminosäureester von nukleosid analogen
GB9317146D0 (en) * 1993-08-18 1993-10-06 Wellcome Found Therapeutic combinations
GB9320316D0 (en) * 1993-10-01 1993-11-17 Smithkline Beecham Plc Pharmaceuticals
TW282470B (pt) * 1993-11-18 1996-08-01 Ajinomoto Kk
DE69513313T2 (de) * 1994-02-01 2000-07-13 Ajinomoto Co., Inc. Verfahren zur Herstellung von Nukleinsäurebasenderivaten
PE32296A1 (es) * 1994-07-28 1996-08-07 Hoffmann La Roche Ester de l-monovalina derivado de 2-(2-amino-1,6-dihidro-6-oxo-purin-9-il) metoxi-1,3-propandiol y sus sales farmaceuticamente aceptables
US5543414A (en) * 1994-07-28 1996-08-06 Syntex (Usa) Inc. Achiral amino acid acyl esters of ganciclovir and its derivatives
US5840891A (en) * 1994-07-28 1998-11-24 Syntex (U.S.A.) Inc. 2-(2-amino-1,6-dihydro-6-oxo-purin-9-yl) methoxy-1,3-propanediol derivative
GB9501178D0 (en) * 1995-01-20 1995-03-08 Wellcome Found Guanine derivative
GB9501127D0 (en) * 1995-01-20 1995-03-08 Wellcome Found Tablet
GB9501142D0 (en) * 1995-01-20 1995-03-08 Wellcome Found Compounds for use in medicine
DE19536164A1 (de) * 1995-09-28 1997-04-03 Boehringer Ingelheim Kg Verbessertes Verfahren zur Herstellung von 9-[(2-Hyroxyethoxy)methyl]guanin (Acyclovir)
PT874631E (pt) * 1996-01-19 2004-04-30 Glaxo Group Ltd Utilizacao de valaciclovir para a manufactura de um medicamento para o tratamento de herpes genital por aplicacao diaria unica
US5700936A (en) * 1996-01-26 1997-12-23 Syntex (U.S.A.) Inc. Process for preparing a 2-(2-amino-1,6-dihydro-6-oxo-purin-9-yl) methoxy-1,3-propanediol valinate
US5840890A (en) * 1996-01-26 1998-11-24 Syntex (U.S.A.) Inc. Process for preparing a 2-(2-amino-1,6-dihydro-6-oxo-purin-9-yl)methoxy-1,3-propanediol derivative
JP4094667B2 (ja) * 1996-01-26 2008-06-04 エフ・ホフマン―ラ ロシュ アーゲー プリン誘導体の製造方法
US5756736A (en) * 1996-01-26 1998-05-26 Syntex (U.S.A.) Inc. Process for preparing a 2-(2-amino-1,6-dihydro-6-oxo-purin-9-yl)methoxy-1,3-propanediol derivative
US6040446A (en) 1996-01-26 2000-03-21 Syntex (U.S.A.) Inc. Process for preparing a 2-(2-amino-1,6-dihydro-6-oxo-purin-9-yl) methoxy-1,3-propanediol derivative
US6703394B2 (en) 1996-02-16 2004-03-09 Medivir Ab Acyclic nucleoside derivatives
US5869493A (en) 1996-02-16 1999-02-09 Medivir Ab Acyclic nucleoside derivatives
IT1283447B1 (it) * 1996-07-18 1998-04-21 Ind Chimica Srl Processo di preparazione del valaciclovir e relativi intermedi
CN1250449A (zh) * 1997-01-17 2000-04-12 味之素株式会社 新型z－伐昔洛韦结晶
CA2332961A1 (en) * 1998-05-21 1999-11-25 Michael Zasloff A method for stimulation of defensin production by exposure to isoleucine
US6849736B2 (en) * 2001-09-07 2005-02-01 Teva Pharmaceutical Industries Ltd. Crystalline forms of valacyclovir hydrochloride
AU2003240213A1 (en) 2002-06-24 2004-01-06 Ranbaxy Laboratories Limited Process for the preparation of robust formulations of valacyclovir hydrochloride tablets
US20050043329A1 (en) * 2002-09-06 2005-02-24 Shlomit Wizel Crystalline forms of valacyclovir hydrochloride
CN1309732C (zh) * 2002-10-28 2007-04-11 南京长澳医药科技有限公司 6－烷氧基－2’，3’－双脱氧鸟嘌呤核苷的制备方法
US20050085491A1 (en) * 2003-06-02 2005-04-21 Igor Lifshitz Novel crystalline forms of valacyclovir hydrochloride
CN1331471C (zh) * 2003-09-22 2007-08-15 陈云芳 盐酸万乃洛韦软胶囊组合物
MXPA06008197A (es) * 2004-01-21 2007-04-02 Teva Pharma Proceso para la preparacion de clorhidrato de valaciclovir.
GB2413017A (en) * 2004-04-06 2005-10-12 Ford Global Tech Llc An electrical connector for a vehicle
WO2006035452A1 (en) * 2004-09-27 2006-04-06 Matrix Laboratories Ltd Novel pseudomorph of valaciclovir hydrochloride
ATE546451T1 (de) 2005-05-25 2012-03-15 Lilly Co Eli Cyclopropancarbonsäureester von acyclovir
EP1746098A1 (en) 2005-07-21 2007-01-24 SOLMAG S.p.A. Valacyclovir polymorphs and a process for the preparation thereof
CN101456859B (zh) * 2009-01-06 2011-07-20 华南理工大学 抗病毒药物缬昔洛韦的制备方法
WO2011158252A1 (en) 2010-06-15 2011-12-22 Matrix Laboratories Ltd Process for the preparation of valacyclovir hydrochloride polymorphic form ii
CN102850354B (zh) * 2012-10-10 2014-07-23 山东金城医药化工股份有限公司 高纯度cbz-万乃洛韦的制备方法
CN106632335A (zh) * 2016-12-27 2017-05-10 河南康达制药有限公司 一种盐酸伐昔洛韦的制备方法
RU2750867C1 (ru) * 2020-05-18 2021-07-05 Александр Сергеевич Самойлов Производные гуанина

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL8202626A (nl) * 1982-06-29 1984-01-16 Stichting Rega V Z W Derivaten van 9-(2-hydroxyethoxymethyl)guanine.
DE3627024A1 (de) * 1985-09-24 1987-04-02 Hoechst Ag In 6- und 9-stellung substituierte 2-aminopurine, ihre verwendung, diese purine enthaltende arzneimittel und verfahren zur herstellung der purine
DE3534774A1 (de) * 1985-09-30 1987-04-02 Robugen Gmbh Nucleosid-analoge verbindungen mit antiviraler aktivitaet, verfahren zu deren herstellung sowie arzneimittel mit antiviraler wirkung
AP160A (en) * 1987-08-15 1991-11-18 The Wellcome Foundation Ltd Therapeutic acyclic nucleosides.

Also Published As

Publication number Publication date
AU2097888A (en) 1989-02-16
JPS6468373A (en) 1989-03-14
HU201071B (en) 1990-09-28
AU612393C (en) 2006-08-17
NO167805C (no) 1991-12-11
EP0308065B1 (en) 1995-01-04
PT88261B (pt) 1995-03-01
IE65551B1 (en) 1995-11-01
CN1033701C (zh) 1997-01-01
CN1032538A (zh) 1989-04-26
FI89713C (fi) 1993-11-10
DE3855333D1 (de) 1996-07-04
DK170803B1 (da) 1996-01-22
FI89713B (fi) 1993-07-30
MX9203418A (es) 1992-07-01
SA95160244B1 (ar) 2006-10-02
MY103760A (en) 1993-09-30
PL158285B1 (en) 1992-08-31
ES2087639T3 (es) 1996-07-16
LV5264A3 (lv) 1993-10-10
KR960004940B1 (ko) 1996-04-18
SU1634138A3 (ru) 1991-03-07
NO167805B (no) 1991-09-02
AP8800099A0 (en) 1988-08-01
DK82694A (da) 1994-07-08
NL960001I1 (nl) 1996-03-01
DK451388D0 (da) 1988-08-12
KR890003761A (ko) 1989-04-17
JPH0662623B2 (ja) 1994-08-17
DK451388A (da) 1989-02-16
SG26346G (en) 1995-09-01
CY1833A (en) 1995-12-01
FI883757A (fi) 1989-02-16
EP0596542A1 (en) 1994-05-11
AP55A (en) 1989-09-26
DK170045B1 (da) 1995-05-08
IL87434A0 (en) 1989-01-31
EP0308065A3 (en) 1989-09-27
LU88746I2 (fr) 1996-10-04
JPH03115284A (ja) 1991-05-16
DE3855333T2 (de) 1996-12-05
CS8805594A2 (en) 1990-06-13
ATE138660T1 (de) 1996-06-15
NO883612L (no) 1989-02-16
KR960002849B1 (ko) 1996-02-27
EP0308065A2 (en) 1989-03-22
IE882463L (en) 1989-02-15
IL87434A (en) 1993-06-10
NZ225809A (en) 1991-07-26
NL960001I2 (nl) 1996-11-01
AU612393B2 (en) 1991-07-11
CS276903B6 (en) 1992-09-16
NO883612D0 (no) 1988-08-12
JPH07113025B2 (ja) 1995-12-06
GR3020372T3 (en) 1996-09-30
MC1968A1 (fr) 1989-09-29
PL274215A1 (en) 1990-02-19
HUT47935A (en) 1989-04-28
AP160A (en) 1991-11-18
FI883757A0 (fi) 1988-08-12
NO1996015I1 (no) 1996-12-17
EP0596542B1 (en) 1996-05-29

Similar Documents

Publication Publication Date Title
PT88261A (pt) Processo para a preparacao de nucleosidos com efeito terapeutico
BR8802484A (pt) Processo para a preparacao de isocianatos
PT92361A (pt) Processo para a preparacao de agentes terapeuticos quinuclidina
PT88099A (pt) Processo para a preparacao de composicoes farmaceuticas de acetaminofeno orais e de libertacao prolongada
PT88044A (pt) Processo para a preparacao de acidos tetra-hidrocarbazole-1-alcanoicos
PT89264A (pt) Processo para a preparacao de compostos azabiciclicos
BR8803596A (pt) Processo para a preparacao de uma poliolefina
PT90293A (pt) Processo para a preparacao de macrolidos
PT88175A (pt) Processo para a preparacao de benzamidas n-substituidas
PT89205A (pt) Processo para a preparacao de derivados de indano
PT89075A (pt) Processo para a preparacao de diacidos diarilestiril-quinolinicos
BR8804284A (pt) Processo para a preparacao de acidos etercarboxilicos
PT89258A (pt) Processo para a preparacao de carbinois com actividade anti-fungica
BR8802843A (pt) Processo para a preparacao de alcanotriois e alcanopoliois
PT90854A (pt) Processo para a preparacao de 1-aril-2-naftoilaminas
BR8906327A (pt) Processo para a preparacao de organoclorossilanos
PT88181A (pt) Processo para a preparacao de derivados aralquilaminoalcoxifenilo
PT92638A (pt) Processo para a preparacao de poliazamacrociclos mono-n-alquilados
PT89039A (pt) Processo para a preparacao de l-ramnose
BR8802082A (pt) Processo para a preparacao de poliaminas aromaticas polinucleares
PT92365A (pt) Processo para a preparacao de (s)-alfa-etil-2-oxo-1-pirrolidinoacetamida
BR8803678A (pt) Processo para a preparacao de polieteramidas
PT89056A (pt) Processo para a preparacao de hidroxilaminas substituidas
BR8807384A (pt) Processo para a preparacao de anidridos oxi-diftalicos
PT89142A (pt) Processo para a preparacao de cristais de cefem

Legal Events

Date Code Title Description
FG3A Patent granted, date of granting

Effective date: 19940804

TE3A Change of address (patent)

Owner name: WELLCOME FOUNDATION LIMITED, THE

Effective date: 19991006

MM4A Annulment/lapse due to non-payment of fees, searched and examined patent

Free format text: MAXIMUM VALIDITY LIMIT REACHED

Effective date: 20090804